Evidence map›Paper›PMID 42136799›Full record

ArticleTherapeutic advances in drug safety2026

Probable case of anaphylaxis due to hydrocortisone in a septic shock patient.

Yanqin Song, Nina Yang, Dingjin Zhou, Dingge Cai

Abstract readCase Reports
In one paragraph

Article in Therapeutic advances in drug safety, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanqin SongThe Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.ORCID https://orcid.org/0000-0002-8579-3286
Nina YangThe Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.
Dingjin ZhouThe Department of Intensive Care Unit, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, Kunming, China.
Dingge CaiThe Department of Pharmacy, The Second Affiliated Hospital of Yunnan University of Chinese Medicine, No. 161 Dongjiao Road, Kunming 650500, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a case of probable anaphylactic shock induced by intravenous hydrocortisone in a 72-year-old male patient with septic shock. The patient, admitted for management of infected pressure injuries, was initiated on hydrocortisone (200 mg/day) for vasopressor-resistant shock. Within 30 min of the first dose administration, he manifested clinical signs consistent with anaphylaxis, including refractory hypotension, tachycardia, and prolonged capillary refill time. Immediate hydrocortisone discontinuation, aggressive fluid resuscitation, norepinephrine uptitration, intravenous methylene blue administration, and amiodarone initiation for ventricular rate control resulted in hemodynamic stabilization and vital sign normalization. This event was categorized as severe (Hartwig scale level 5) and assessed as probably preventable (Modified Schoumock and Thornton scale). A Naranjo score of four supported a probable adverse drug reaction (ADR). A concurrent disulfiram-like reaction (DLR) secondary to cefoperazone-sulbactam was excluded based on clinical timeline and presentation. This case underscores that glucocorticoids, despite their anti-allergic properties, can precipitate anaphylaxis in critically ill patients, emphasizing the necessity for heightened clinical vigilance and strict adherence to administration guidelines within this vulnerable population.

Indexed as

adverse drug reaction (ADR)anaphylactic shockcase reporthydrocortisone

Identifiers

PMID42136799
PMCPMC13167330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.